To test the hypothesis that discordant growth in monochorionic (MC) twins occurs at least in part due to disparity in placental amino acid transporter function, we measured plasma amino acid levels by HPLC in maternal and fetal blood samples collected at birth from gestational age matched twins with (n ϭ 12) and without (n ϭ 12) twin-twin transfusion syndrome (TTTS). In the donor twin, fetal plasma concentrations and feto-maternal ratios of five essential amino acids-valine (p Ͻ 0.001), leucine (p Ͻ 0.001), iso-leucine (p Ͻ 0.05), histidine (p Ͻ 0.001) and L-arginine (p Ͻ 0.001)-were lower than the recipient and non-TTTS twin pairs. Fetal concentrations of the nonessential amino acids taurine (p Ͻ 0.001), serine (p Ͻ 0.01), glycine (p Ͻ 0.001) and tyrosine (p Ͻ 0.05) were also markedly lower in the donor than the recipient and non-TTTS twin pairs. In contrast, the fetal alanine level in the donor twin was higher than the recipient (664 Ϯ 64 versus 396 Ϯ 23 M; p Ͻ 0.001) and the non-TTTS twin pairs (p Ͻ 0.01). No such differences between amino acid profiles in non-TTTS MC twin pairs were found. Maternal plasma amino acid levels between TTTS and non-TTTS groups were comparable. This study provides the first evidence that certain amino acids in the donor twin of chronic TTTS differ significantly from those of the co-twin while others were comparable between twin pairs. These data, therefore, argue against inter-twin transfusion as the sole cause of growth restriction of the donor twin and suggests instead that impaired placental transport of amino acids may be a likely mechanism. Abbreviations MC, monochorionic F/M, feto-maternal ratio IUGR, intrauterine growth restriction TTTS, twin, twin transfusion syndrome AGA, appropriate for gestational age DC, dichorionic Perinatal death and postnatal handicap are more common in monochorionic (MC) than dichorionic (DC) twins (1). The high perinatal mortality in MC twins has been attributed to the presence of vascular anastomoses in the placenta, which may lead to twin-twin transfusion syndrome (TTTS) (2).Twin-twin transfusion syndrome is a chronic condition that presents in the early mid trimester of pregnancy, with characteristic discordance in fetal growth and amniotic fluid volume (1). Severe polyhydramnios develops in the larger "recipient" twin's sac, while oligohydramnios ensues in the growth restricted "donor" twin's sac. As pregnancy progresses, both fetuses are at a substantial risk of perinatal mortality and morbidity. The donor twin is at risk of the well described complications of severe intrauterine growth retardation, while the recipient twin may develop hydrops, cardiac dilatation, myocardial hypertrophy, tricuspid regurgitation, right ventricular outflow obstruction, and renal failure (3).Despite recent advances in the diagnostic and therapeutic modalities in fetal medicine, the treatment of chronic TTTS remains far from satisfactory (4, 5). This is attributed to the poor understanding of the patho-physiology of this enigmatic condition. Recent vascular anast...